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Abstract 
Introduction: Corticoid therapy is well-known to improve the symptoms of psoriasis. 
Addison’s disease is an autoimmune disease which leads to a loss of cortisol production 
in the adrenal glands. This case report describes a patient with wide-spread psoriasis for 
34 years who was cured when Addison’s disease was detected and substitution to reach 
normal biological cortisol levels was introduced.  
Case Report: A 59-year-old man was diagnosed with Addison’s disease. He had been 
tired for several years and had had difficulties in continuing his work. His brother had 
Addison’s disease and recommended him to make a screen for the disease. Synacthen 
test diagnosed Addison’s disease with a clear deficiency of cortisol production. After 
substitution with hydrocortisone the patient’s constitution improved rapidly and he felt 
no longer tired during work. At the same time, all skin lesions of psoriasis disappeared as 
well as aches in several joints, both symptoms having been present for a couple of 
decades. Previously, salves of cortisol had been used to reduce the symptoms of 
psoriasis, but now, 1–2 years later, after the treatment of Addison’s disease, no 
symptoms in the skin or joints have reoccurred.  
Conclusions: This report illustrates that Addison’s disease, although a rare condition, 
should be kept in mind before treatment of psoriasis is started. Especially if other 
symptoms such as fatigue are present, a screening test of serum cortisol in the morning 
should be liberally made. The report also illustrates a need of examining corticoid levels 
in patients with psoriasis compared to the general population. 
 
Introduction 
Psoriasis is a common disease with commonly wide-spread skin lesions [1]. Corticoid 
therapy is well-known to improve the symptoms of psoriasis. Addison’s disease is an 
autoimmune disease which leads to a loss of cortisol production in the adrenal glands [2].  
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Addison’s disease is often accompanied by tiredness and a disturbed salt regulation due to 
a deficiency of the hormones aldosterone and cortisol normally produced in the adrenal 
glands [2]. In the acute phase of Addison’s disease stomach aches and nausea also exist. 
Since cortisol levels are important for the symptoms of psoriasis, the question arises 
whether patients with suboptimal cortisol production develop psoriasis more easily. This 
case report describes a patient with wide-spread psoriasis for 34 years, which was cured 
when Addison’s disease was detected and substitution to reach normal biological cortisol 
levels was introduced. 
Case Report 
At 59 years of age, this patient was diagnosed with Addison’s disease in our endocrinologic 
outpatient clinic. He had a brother with Addison’s disease who recommended him to screen for the 
disease since the present patient had had similar symptoms of grave fatigue for several years. Serum 
cortisol showed a low morning value when tested in the primary care unit and Addison’s disease was 
confirmed by synacthen test in our clinic. 
When the patient was 28 years old, psoriasis appeared on the skull, arms, elbows, knees, hollows of 
the knees, calves and hands. Since then, he has been using corticoid salves to reduce these symptoms. 
He has also had aches in several joints, although no diagnosis has been made and no specific treatment 
has been prescribed. Both proximal and distal joints of the fingers, the hip and the distal joint of the big 
toe have been affected. 
After diagnosis of Addison’s disease I prescribed hydrocortisone 20 mg, 1 pill in the morning and 
half a pill in the evening, to keep normal biological cortisol levels. The fatigue, which had been present 
for many years, rapidly disappeared and the patient had no longer any limitations in managing his 
work, which had previously been a problem. Simultaneously, the skin lesions of psoriasis, which had 
been present for 30 years, totally disappeared. There was no longer any need for corticoid salves. 
Furthermore, the aches in all joints disappeared. 
Discussion 
This case report illustrates two important aspects to consider in the clinical treatment 
of psoriasis and arthritis as well as in research concerning these conditions. It illustrates 
that Addison’s disease, although a rare condition, should be kept in mind before 
treatment of psoriasis or arthritis is started. Especially if other symptoms such as fatigue 
are present, a screening test of serum cortisol in the morning should be made. The report 
also illustrates a need of examining corticoid levels in patients with psoriasis compared to 
the general population. It could be questioned whether psoriasis or arthritis develops in 
some patients due to a suppressed cortisol production in the adrenal glands. 
In the present report, a patient had skin lesions of psoriasis over 3 decades, which 
disappeared when Addison’s disease was detected and substitution to reach normal 
cortisol levels was introduced. It is difficult to know for how long the patient had had a 
reduced levels of cortisol and whether this could be the cause of psoriasis during the 
whole course of the disease. The levels of cortisol had certainly been substantially reduced 
for several years, since the patient could remember the grave fatigue he had felt for many 
years, a fatigue which rapidly disappeared when Addison’s disease was detected and 
treated. Hence, it is also possible that a slight suppression even at an early stage of 
psoriasis had existed. 
It is possible that a substitution dose of hydrocortisone could cause a slight increase in 
the cortisol levels compared with normal levels, thus influencing the treatment of  
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psoriasis. However, the cortisol levels obtained by hydrocortisone could lead to an 
increased risk of osteoporosis, and doses of 15–25 mg of hydrocortisone have been found 
to be more appropriate [3]. Hence, in the present case, the finding either indicates that 
suppressed levels of cortisol can lead to the development of psoriasis or that a small dose 
of hydrocortisone could be a potent therapy in patients with psoriasis. 
Psoriasis has been described as one of the most typical psychocutaneous diseases [4]. 
The hypothalamic-pituitary-adrenal (HPA) axis function has been suggested as essential 
in the development of psoriasis and several psychiatric disorders and psychosomatic 
diseases. However, the evidence of a reduced response of the HPA axis in psoriasis after 
psychosocial stress is diverging and difficult to study [4]. In psoriasis arthritis, TNF-α-
antibodies, which have a potent effect on symptoms, have proved to increase the relative 
production of cortisol in the adrenal glands compared with other adrenal hormones [5]. 
This could indicate the importance of a balanced cortisol production for both psoriasis 
and psoriasis arthritis. This report supports the importance of an adequate endogenous 
cortisol balance in the pathogenesis and treatment of psoriasis and psoriasis arthritis. 
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